During secondary pneumococcal infection of the influenza-infected lung, TNFSF14-deficient mice displayed significantly increased AM abundance, decreased bacterial burdens, mitigated weight loss, and improved survival. This evidence concerns the gene TNFSF14 and pneumococcal infection.